Brief: Touyun Biotech FY Loss Attributable HK$72.9 Mln
31/03/2022 13:23
March 31 (Reuters) - Touyun Biotech Group Ltd 1332.HK :
* FY REVENUE FROM SALES OF GOODS AND SERVICES RENDERED
HK$291.4
MILLION VERSUS HK$218.8 MILLION
* FY LOSS ATTRIBUTABLE HK$72.9 MILLION VERSUS LOSS OF
HK$168.8
MILLION
Source text for Eikon: ID:nHKS9kgJrM
Further company coverage: 1332.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Touyun Biotech
See all newsHong Kong's Touyun Biotech profit surges on fair value gains
Brief: Touyun Biotech Group Sees Hk$180 Million-Hk$200 Million Profit And Total Comprehensive Income Attributable For HY2026
Brief: Touyun Biotech To Issue 123 Million New Shares At Hk$0.122 Per Share
Brief: Touyun Biotech Appoints Zhou Ruijuan As Executive Director And Vice Chairlady
Brief: Touyun Biotech Group Posts FY Revenue HKD 67 Million